Abstract: A process for producing a supported mesoporous and microporous material, comprises contacting a support with a template to produce a supported template, and contacting the supported template with one or more microporous material precursor to produce a supported microporous material-template composite, and subsequently removing the template from the supported microporous material-template composite to produce the supported mesoprous and microporous material. A composition comprising a supported mesoprous and microporous material produced by this process can be used for methane dehydroaromatization.

Abstract: A catalytic composition and method for methane dehydroaromatisation, the catalytic composition comprising a catalyst metal active for methane dehydroaromatisation, a zeolite having pores with diameters of at least 10 non-oxygen frame-work atoms, and silicon carbide, and in which the method comprises contacting a methane-containing feedstock with said catalytic composition to produce one or more aromatic compounds and hydrogen.

Abstract: A process for producing porous silicon carbide comprising mixing particles of silicon carbide reactant with particles of carbon, and calcining the mixture in an atmosphere comprising molecular oxygen at a temperature in excess of 950° C., wherein the silicon carbide:carbon mass ratio in the mixture is in the range of from 5:1 to 1:10.

Abstract: Disclosed is a recombinant human adenovirus type 5 adenovirus construct, in which a 920-946 nt sequence of ADV5 genome and a 28532-29360 nt sequence of the E3 region are deleted while a foreign cDNA fragment is reversely inserted into the deleted E3 region. A method for preparing the recombinant ADV5 construct is also provided. The construct provided herein presents a tumor-specific replication, tumor-specific expression of the inserted anti-gene and tumor-specific bystander effects, and is suitable for use in tumor therapy.

Abstract: Disclosed is a recombinant human adenovirus type 5 adenovirus construct, in which a fragment in the E1A region of the ADV5 genome and a fragment in the E3 region are deleted while a foreign cDNA fragment is reversely inserted into the deleted E3 region. A method for preparing the recombinant ADV5 construct is also provided. The construct provided herein presents a tumor-specific replication, tumor-specific expression of the inserted anti-gene and tumor-specific bystander effects, and is suitable for use in tumor therapy.